Baby formula maker Abbott Labs agrees to settlement over closure of largest US plant
- Abbott Laboratories will pay $385 million to resolve legal claims arising from a contamination inquiry at its baby formula manufacturing plant in Sturgis, Michigan, the nation's largest, which triggered severe supply shortages in 2022.
- Concerns regarding the facility resulted in a lawsuit by the Justice Department alongside a sweeping recall of powdered formula products.
- Affecting multiple major lines such as Similac, the recall further strained inventory already burdened by supply chain bottlenecks and stockpiling during COVID-19 shutdowns.
Unverified
- Abbott Laboratories will pay $385 million to resolve legal claims arising from a contamination inquiry at its baby formula manufacturing plant in Sturgis, Michigan, the nation's largest, which triggered severe supply shortages in 2022.
- Concerns regarding the facility resulted in a lawsuit by the Justice Department alongside a sweeping recall of powdered formula products.
- Affecting multiple major lines such as Similac, the recall further strained inventory already burdened by supply chain bottlenecks and stockpiling during COVID-19 shutdowns.
Sources: The Independent